SEC Form 4

FORM 4		UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5
	Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X	Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person* Smith Melissa D (Last) (First) (Middle) C/O WEX INC. 1 HANCOCK STREET (Street) PORTLAND MAINE 04101 (City) (State) (Zip) UNITED STATES (Country)	2. Issuer Name and Ticker or Trading Symbol WEX Inc. [ WEX ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X Director 10% Owner X Officer (give title below) Other (specify below) CEO and President
	2a. Foreign Trading Symbol
	3. Date of Earliest Transaction (Month/Day/Year) 09/01/2026	6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person
	4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/01/2026		M(1)		23,187	A	$104.95	149,812(2)	D
Common Stock	09/01/2026		M(1)		4,922	A	$99.69	154,734	D
Common Stock	09/01/2026		S(1)		180	D	$186.48(3)(4)	154,554	D
Common Stock	09/01/2026		S(1)		9,245	D	$189.12(4)(5)	145,309	D
Common Stock	09/01/2026		S(1)		7,575	D	$189.87(4)(6)	137,734	D
Common Stock	09/01/2026		S(1)		11,109	D	$191.11(4)(7)	126,625	D
Common Stock								18,277	I	By husband
Common Stock								1,693	I	FBC Irrevocable Trust(8)
Common Stock								1,692	I	BDC Irrevocable Trust(8)
Common Stock								1,693	I	GMC Irrevocable Trust(8)
Common Stock								42,274	I	Melissa D. Smith 2025 Trust(9)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$104.95	09/01/2026		M(1)			23,187	(10)	03/20/2027	Common Stock	23,187	$0	0	D
Stock Option (right to buy)	$99.69	09/01/2026		M(1)			4,922	(11)	05/10/2027	Common Stock	4,922	$0	0	D

Explanation of Responses:

1. The reported exercise of options and subsequent sale of shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 6/2/2026. The reporting person exercised two stock option awards that were scheduled to expire on March 20, 2027 and May 10, 2027, respectively. The options would have been forfeited if not exercised prior to their respective expiration dates.

2. Reflects distribution of 14,809 shares of common stock in accordance with the terms of the trust on August 28, 2026, from the Melissa D. Smith 2024 Trust, which are now directly held by the reporting person.

3. The price listed is a weighted average price. These shares were sold for between $186.30 and $186.65, inclusive.

4. Upon request, the reporting person will provide the Securities and Exchange Commission, WEX Inc. or any security holder of WEX Inc. with full information regarding the number of shares sold at each separate purchase price.

5. The price listed is a weighted average price. These shares were sold for between $188.26 and $189.25, inclusive.

6. The price listed is a weighted average price. These shares were sold for between $189.50 and $190.19, inclusive.

7. The price listed is a weighted average price. These shares were sold for between $191.11 and $191.17, inclusive.

8. This trust was first described in a Form 4 filed by the reporting person on 06/28/2022.

9. This trust was first described in a Form 4 filed by the reporting person on 02/25/2026.

10. This stock option vested with respect to one-third of these shares each on 03/20/2018, 03/20/2019, and 03/20/2020.

11. Half of the performance based non-statutory stock options ("Performance-Based NSOs") reported on the reporting person's Form 4 dated May 12, 2017 (the "Original Form 4"), vested on June 26, 2020 when the Company's closing stock price was at least $149.54 for twenty consecutive trading days. Another quarter of the Performance-Based NSOs vested on December 29, 2020 when the Company's closing stock price was at least $174.45 for twenty consecutive trading days. The last remaining quarter of the Performance-Based NSOs vested on March 8, 2021 when the Company's closing stock price was at least $199.38 for twenty consecutive trading days. Please reference the Original Form 4 for further information regarding the vesting of the Performance-Based NSOs.

Remarks:

	/s/ Matthew Finkelstein, as attorney in-fact for Melissa D. Smith	09/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)